PL2079441T3 - Miejscowa kompozycja antybiotykowa do zapobiegania chorobie z Lyme - Google Patents

Miejscowa kompozycja antybiotykowa do zapobiegania chorobie z Lyme

Info

Publication number
PL2079441T3
PL2079441T3 PL08786388T PL08786388T PL2079441T3 PL 2079441 T3 PL2079441 T3 PL 2079441T3 PL 08786388 T PL08786388 T PL 08786388T PL 08786388 T PL08786388 T PL 08786388T PL 2079441 T3 PL2079441 T3 PL 2079441T3
Authority
PL
Poland
Prior art keywords
prevention
lyme disease
antibiotic composition
topical antibiotic
borrelia burgdorferi
Prior art date
Application number
PL08786388T
Other languages
English (en)
Inventor
Gustave Huber
Uta Hüttenes
Bidder Caroline Roosens-Von
Original Assignee
Ixodes Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ixodes Gmbh filed Critical Ixodes Gmbh
Publication of PL2079441T3 publication Critical patent/PL2079441T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL08786388T 2007-07-25 2008-07-24 Miejscowa kompozycja antybiotykowa do zapobiegania chorobie z Lyme PL2079441T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07113143 2007-07-25
PCT/EP2008/059696 WO2009013331A1 (en) 2007-07-25 2008-07-24 Topical antibiotic composition for the prevention of lyme disease
EP08786388A EP2079441B1 (en) 2007-07-25 2008-07-24 Topical antibiotic composition for the prevention of lyme disease

Publications (1)

Publication Number Publication Date
PL2079441T3 true PL2079441T3 (pl) 2011-02-28

Family

ID=39149162

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08786388T PL2079441T3 (pl) 2007-07-25 2008-07-24 Miejscowa kompozycja antybiotykowa do zapobiegania chorobie z Lyme

Country Status (15)

Country Link
US (2) US8710019B2 (pl)
EP (1) EP2079441B1 (pl)
JP (1) JP2010534221A (pl)
AT (1) ATE481964T1 (pl)
AU (1) AU2008280131B9 (pl)
CA (1) CA2694403C (pl)
CY (1) CY1110971T1 (pl)
DE (1) DE602008002692D1 (pl)
DK (1) DK2079441T3 (pl)
ES (1) ES2349906T3 (pl)
HR (1) HRP20100699T1 (pl)
PL (1) PL2079441T3 (pl)
PT (1) PT2079441E (pl)
SI (1) SI2079441T1 (pl)
WO (1) WO2009013331A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
CN107148480A (zh) * 2014-05-09 2017-09-08 张颖 对伯氏疏螺旋体的新型抗病毒活性的鉴定
JP6777734B2 (ja) 2015-06-10 2020-10-28 ピードモント アニマル ヘルス インコーポレイテッド 注射可能な抗生物質製剤及びその使用
EP3252470B1 (en) 2016-06-03 2020-07-29 Te?ted Oy A method and a solid support for detecting tick-borne microbes in a biological sample

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1090253A (en) * 1976-11-01 1980-11-25 Edward D. Thompson Anti-acne composition
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
WO1998043673A1 (en) * 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies, Inc. Solvent system for enhanced penetration of pharmaceutical compounds
US7179475B1 (en) * 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
US6589568B2 (en) * 2001-02-16 2003-07-08 Nurad, Inc. Therapeutic body lotion containing alkali metal hypohalite
NZ532074A (en) * 2001-11-06 2006-02-24 Maxim Pharm Inc Compositions for the treatment of infectious diseases
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
CY1110971T1 (el) 2015-06-11
AU2008280131B9 (en) 2014-11-13
CA2694403C (en) 2013-09-24
EP2079441B1 (en) 2010-09-22
HRP20100699T1 (hr) 2011-01-31
JP2010534221A (ja) 2010-11-04
DK2079441T3 (da) 2010-12-13
AU2008280131A8 (en) 2010-03-04
CA2694403A1 (en) 2009-01-29
SI2079441T1 (sl) 2010-12-31
ATE481964T1 (de) 2010-10-15
DE602008002692D1 (de) 2010-11-04
WO2009013331A1 (en) 2009-01-29
ES2349906T3 (es) 2011-01-12
US8710019B2 (en) 2014-04-29
AU2008280131B2 (en) 2014-06-26
US20100130437A1 (en) 2010-05-27
PT2079441E (pt) 2010-11-19
EP2079441A1 (en) 2009-07-22
US20140194375A1 (en) 2014-07-10
US9610244B2 (en) 2017-04-04
AU2008280131A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
WO2010063996A3 (en) Antibacterial compounds
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
TW200734344A (en) Antibacterial agents
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
WO2007143607A3 (en) Method of treating atrophic vaginitis
UA107783C2 (en) Isoindoline compounds for use in treating cancer
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2009062576A3 (en) Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
CY1110971T1 (el) Τοπικη αντιβιοτικη συνθεση για την προληψη της νοσου lyme
WO2007124382A3 (en) Inhaled imipenem
HK1137947A1 (en) Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
WO2013166282A3 (en) Methods and compositions for treating bacterial infection
IL218388A (en) Hydroxyphenyl compounds, pharmaceuticals containing them, their use in the treatment of antimicrobial infections, their preparation and intermediates in the process
MX2009009074A (es) Macrolidos basados en eritromicina.
MX2010004859A (es) Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso.
WO2012061767A3 (en) Defensin-like molecules as novel antimicrobial agents
MX2012004282A (es) Composiciones farmaceuticas.
SG178936A1 (en) Compositions and methods for treating bacterial infections using ceftaroline
WO2009124086A3 (en) Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections